GlobeNewswire 12/4/2025 Press Release: Sanofi completes acquisition of Vicebio

GlobeNewswire 12/2/2025 Zevra Therapeutics, Inc. Appoints Alicia Secor to Board of Directors; Announces Retirement of Wendy ...

GlobeNewswire 12/2/2025 Ovid Therapeutics Appoints Dr. Petra Kaufmann as Chief Medical Officer

GlobeNewswire 12/1/2025 Altimmune Announces CEO Transition and Succession Plan

GlobeNewswire 12/1/2025 Nurix Therapeutics Announces Webcast to Review New and Updated Data from the Phase 1 Clinical Trial ...

GlobeNewswire 12/1/2025 Regeneron and Tessera Therapeutics to Jointly Develop TSRA-196, an Investigational Gene Editing Ther...

GlobeNewswire 11/26/2025 Valneva to Further Consolidate its Operations in France

GlobeNewswire 11/26/2025 CG Oncology Announces New Board Member and Board Transition

GlobeNewswire 11/25/2025 TailorCare Forms AI Advisory Board to Advance Value-Based Care Innovation in Musculoskeletal Health

GlobeNewswire 11/25/2025 Nurix Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference

GlobeNewswire 11/25/2025 Dupixent® (dupilumab) Approved as the First Targeted Medicine in the European Union (EU) in Over a D...

GlobeNewswire 11/25/2025 Press Release: Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the EU in ...

GlobeNewswire 11/19/2025 EYLEA HD® (aflibercept) Injection 8 mg Approved by FDA for the Treatment of Macular Edema Following ...

GlobeNewswire 11/19/2025 Libtayo® (cemiplimab) Approved in the European Union as First and Only Immunotherapy for Adjuvant Tr...

GlobeNewswire 11/18/2025 ONLYLYON Leads Delegation to New York and Boston to Strengthen Transatlantic Partnerships in Lyon

GlobeNewswire 11/17/2025 Dr. Vignesh Rajah Appointed as SERB Pharmaceuticals’ Chief Medical Officer

GlobeNewswire 11/14/2025 Press Release: Sanofi’s Teizeild recommended for EU approval by the CHMP for patients with stage 2 t...

GlobeNewswire 11/13/2025 Cingulate Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update

GlobeNewswire 11/13/2025 Regeneron Highlights Progress at American Society of Hematology (ASH), with Updated Data in Multiple...

GlobeNewswire 11/13/2025 T-Therapeutics announces Series A extension to $91 million to advance first-in-class bispecifics tow...

GlobeNewswire 11/12/2025 Immuneering Reports Third Quarter 2025 Financial Results and Provides Business and Clinical Updates

GlobeNewswire 11/12/2025 MacroGenics Reports Third Quarter 2025 Financial Results and Provides Update on Corporate Progress

GlobeNewswire 11/11/2025 Metagenomi Reports Third Quarter 2025 Financial Results and Announces Strategic Pipeline Prioritizat...

GlobeNewswire 11/11/2025 RECORDATI FIRST NINE MONTHS 2025 RESULTS: REVENUE +12.2%, EBITDA(1) +11.8%, ADJUSTED NET INCOME(2) +...